PET/CT brain scans of the enzyme aromatase could help providers pinpoint which patients will struggle with obesity and self-regulation.
PET scans can be a crystal ball, helping providers predict whether men and women will struggle with obesity and poor self-regulation.
These images of the amygdala shed light on the relationship between aromatase, an enzyme associated with the production and processing of estrogen, and higher body mass index (BMI) and diminished self-control. A team of investigators from Stony Brook University shared their discovery in an article published on Aug. 31 in PNAS.
According to their analysis, the team’s findings indicate that imaging aromatase in the brain could be a unique way to characterize the role estrogen plays in obesity and other conditions where self-regulation can be impaired.
To test how estrogen influences body weight and stimuli-induced behavior, the researchers, led by Anat Beigon, Ph.D. professor of radiology and Director of the Center on Gender, Hormones, and Health at Stonybrook’s Renaissance School of Medicine, used an aromatase-specific radiotracer with PET imaging to measure levels of the enzyme in the brains of 43 men and women. Participants were in the healthy to obese weight ranges. Their average age was 40 years, and their average BMI was 28.
“This is the first study to show a direct correlation between aromatase availability in the amygdala and BMI,” Beigon said. “It is also the first to how an inverse correlation between amygdala aromatase and self-control in the same individuals.”
Based on their regression model analysis that controlled for both sex and age, she said, amygdala aromatase affected men and women similarly. Consequently, it has the potential to be a sex neutral contributor to BMI, making it a possible measurable marker for both men and women who struggle with obesity and self-regulation.
Further work is needed to fully understand the role of estrogen, however, she said. The next step is to examine other brain regions where estrogen is shown to influence appetite and energy use. These investigations could determine how valuable aromatase measurements are in discriminating between binge eating and healthy populations, as well as predicting whether a patient will regain wait after bariatric surgery.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.
2 Commerce Drive
Cranbury, NJ 08512